Searched for
EUA FOR CORBEVAX
'Corbevax under WHO's detailed review for emergency use listing'The WHO website states that the rolling data submission has begun on June 10 and the decision date on EUL is yet to be confirmed. The compa...- Biological E. cuts price of its COVID-19 vaccine to Rs 250 per doseIt would result in end users paying a price of Rs 400 a dose, including taxes and administration charges, the company said in a statement. ...
- Biological E seeks EUA for Corbevax as booster in adults vaccinated with Covishield, CovaxinThe Drugs Controller General Of India (DCGI) had already approved Corbevax, India's first indigenously developed RBD protein subunit vaccin...
- Covid-19: SEC approves Corbevax for use in kids aged 5-12 yearsCorbevax is currently being administered to children in the age group 12-14 years. Hyderabad based Biological E had approached the drug reg...
- Corbevax to cost Rs 800 in market & Rs 145 for the govt"Our price to the government programme is ₹145, the lowest in the country and possibly the world," Datla said. "It's something we take grea...
- DCGI's EUA nod to SII's Covovax for 12-17 yrs age group; Poonawalla says younger age groups to follow shortlyIt is the fourth vaccine to receive the regulator's nod for use among those below 18 years.
- The more vaccines, vaccinated the betterThe pandemic is not over. There is a need to ensure universal vaccination at home and abroad. India needs to move quickly on its domestic r...
- Subject Expert Committee recommends EUA for BE's Covid jab Corbevax for 12-18 years age groupCorbevax, is a RBD protein sub-unit vaccine that has been developed with support from the Department of Biotechnology and the Biotechnology...
- Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age groupThe Drugs Controller General Of India (DCGI) has already approved Corbevax, which is India's first indigenously developed RBD protein sub-u...
- NTAGI may meet on Friday to review Covovax, CorbevaxBoth SII and Biological E are conducting Phase III trials of their vaccines on children. These could become the next choices of vaccines fo...
- No plan yet to take two new shots in Centre's vaccination driveThe government had placed an order for Corbevax even before it received emergency use authorisation (EUA). It paid ₹1,500 crore in advance ...
- India's drug regulator wants more data on Russia's one-shot Sputnik Light vaccineSputnik V is a two-dose vaccine made from two components - recombinant adenovirus 26 or Ad26 and adenovirus 5 or Ad5 The first dose (Ad26) ...
- India-US healthcare collaboration in spotlight as India approves two more COVID-19 vaccinesTaranjit Singh Sandhu, India's Ambassador to the US, in a tweet described it as a model of India-US healthcare collaboration. "Models of wh...
- Good news on Covid therapy frontExperience with the Omicron variant so far makes clear that while vaccines are critical for reducing the virulence of the disease, therapie...
- COVID-19: Corbevax, Covovax, Molnupiravir approved for emergency useUnion Health Minister Mansukh Mandaviya on Tuesday said that the Central Drug Authority CDSCO has approved the Serum Institute of India's C...
- A game-changing pill and two new vaccines will bolster India's fight against Covid variantsThe recommendations have been sent to the Drug Controller General of India (DCGI), which will soon decide on their approval, people in the ...
- Government panel recommends EUA for COVID-19 vaccines Covovax, Corbevax and anti-Covid pill molnupiravirThe SEC on COVID-19 of the CDSCO, which reviewed the emergency use authorisation (EUA) applications of Serum Institute of India (SII) for t...
- Experts panel to review applications of Covovax & Corbevax jabs; Merck's Covid drug todayThe subject experts committee (SEC), a body under India's drug regulator, will meet on Monday to review the applications for granting appro...
- India needs new vaccine launches to meet targetsThe government had in a presentation in May estimated that 216 crore vaccines will be available in the country between August and December.
- Biological E plans to break into the big league by manufacturing three Covid-19 vaccinesOf these, the phase-three trials of Corbevax — jointly manufactured by BE, Baylor College of Medicine in Houston and Dynavax in California ...
Load More
